Back to search
Phenylketonuria (PKU) and Hyperphenylalaninemia
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Phenylketonuria (PKU) and Hyperphenylalaninemia trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Phenylketonuria (PKU) and Hyperphenylalaninemia trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
Study 165-401 is a Phase 4, open-label study designed to examine the concomitant use of methotrexate (MTX) to suppress immune responses to Palynziq and improve…
Hyperphenylalaninemia is not only present in patients with congenital phenylketonuria. In adults with critical illness, hyperphenylalaninemia is noted in some p…
Phenylketonuria (PKU) is a metabolic disease of genetic origin. This is a rare disease (incidence 1 / 16000 births) which is the subject of a systematic neonata…
The goal of this observational study is to evaluate the performance of the PheCheck™ test for the rapid detection of phenylalanine (Phe) from a fingerstick samp…